- Time of issue:2021-02-08 16:38:20
In KYinno, more than 50 scientists are dedicated to offer a comprehensive and integrated antibody solution, including target discovery and validation, antigen design and preparation, Hybridoma/Phage display/Single B cell, high throughput antibody screening, functional validation, humanization and recombinant expression. With our unique technologies, antibodies for many hard targets, such as GPCR and Ion channel, have been successfully generated.
High efficient Electronic fusion can yield over 10,000 hybridoma per fusion. Positive rate is up to 90%. With fast protocol, including specific immunization approach, positive hybridoma can be obtained in 60 days.
With unique GPCR antibody discovery technologies, high affinity/specific monoclonal antibodies can be generated within 60 days.
KYinno Biotechnology Co., Ltd
Cell phone No: +(86)10-58222701 / 58222702
Room 609, No.3 Building, Yizhuang Biomedical Park, No.88, Kechuang Six Street, BDA,
Beijing, China, 101111